The pharmacologic and clinical effects of medical cannabis.

@article{Borgelt2013ThePA,
  title={The pharmacologic and clinical effects of medical cannabis.},
  author={Laura M Borgelt and Kari Lanette Franson and Abraham M. Nussbaum and George Sam Wang},
  journal={Pharmacotherapy},
  year={2013},
  volume={33 2},
  pages={
          195-209
        }
}
  • Laura M Borgelt, Kari Lanette Franson, +1 author George Sam Wang
  • Published 2013
  • Medicine
  • Pharmacotherapy
  • Cannabis, or marijuana, has been used for medicinal purposes for many years. Several types of cannabinoid medicines are available in the United States and Canada. Dronabinol (schedule III), nabilone (schedule II), and nabiximols (not U.S. Food and Drug Administration approved) are cannabis-derived pharmaceuticals. Medical cannabis or medical marijuana, a leafy plant cultivated for the production of its leaves and flowering tops, is a schedule I drug, but patients obtain it through cannabis… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 299 CITATIONS, ESTIMATED 52% COVERAGE

    Cannabis in cancer care.

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Cardiovascular Effects of Marijuana

    Cannabinoids and the kidney: effects in health and disease.

    VIEW 2 EXCERPTS
    CITES BACKGROUND

    Cannabis for Pain and Headaches: Primer

    Medical marijuana in neurology

    VIEW 14 EXCERPTS
    CITES BACKGROUND
    HIGHLY INFLUENCED

    FILTER CITATIONS BY YEAR

    2013
    2020

    CITATION STATISTICS

    • 25 Highly Influenced Citations

    • Averaged 42 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 89 REFERENCES

    Medical marijuana and the developing role of the pharmacist.

    VIEW 2 EXCERPTS

    Cannabis and Its Derivatives: Review of Medical Use

    • Lawrence Leung
    • Medicine
    • The Journal of the American Board of Family Medicine
    • 2011
    VIEW 1 EXCERPT

    Biomarkers for the effects of cannabis and THC in healthy volunteers.

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Cannabinoid pharmacology: the first 66 years.

    VIEW 5 EXCERPTS
    HIGHLY INFLUENTIAL